Other related webinars
New FDA requirements: Recent changes to FDA requ...
Friday, 10th February, 2012
Time : 02:00 PM EST | 11:00 AM PST
Assessing off-label drug use after approval : re...
Friday, 9th March, 2012
Time : 02:00 PM EST | 11:00 AM PST
Reducing risk of international drug development ...
Wednesday, 11th April, 2012
Time : 02:00 PM EST | 11:00 AM PST
Use of risk management plans for integrated bene...
Thursday, 14th June, 2012
Time : 02:00 PM EST | 11:00 AM PST
FDA requirements for Risk Evaluation and Managem...
Friday, 29th June, 2012
Time : 02:00 PM EST | 11:00 AM PST
Enterprise Project Portfolio Management - Moving...
Friday, 12th October, 2012
Time : 02:00 PM EST | 11:00 AM PST
The new concept of Effective Risk Management : A...
Friday, 26th October, 2012
Time : 02:00 PM IST | 09:30 AM CET
Managerial Decision-Making Under Risk and Uncert...
Wednesday, 21st November, 2012
Time : 02:00 PM EST | 11:00 AM PST
Crossing the chasm from Traditional Project Man...
Friday, 7th December, 2012
Time : 02:00 PM EST | 11:00 AM PST
Risk assessment: approaches to avoid medication ...
Monday, 24th December, 2012
Time : 02:00 PM EST | 11:00 AM PST
Risks of not achieving comparability of biologic...
Friday, 18th January, 2013
Time : 02:00 PM EST | 11:00 AM PST
Risk Analysis & Risk Assessment in Drug Discover...
Monday, 4th February, 2013
Time : 02:00 PM EST | 11:00 AM PST
Building A Successful and Sustainable PMO
Friday, 8th February, 2013
Time : 02:00 PM EST | 11:00 AM PST
Achieving the lifecycle approach to process vali...
Wednesday, 20th March, 2013
Time : 02:00 PM EST | 11:00 AM PST
Risk Based Approach to the Management and Monito...
Friday, 3rd May, 2013
Time : 02:00 PM EST | 11:00 AM PST
How to Write a Scientific Article
Friday, 5th June, 2015
Time : 11:00 AM EST | 05:00 PM CET
The New Pipeline Physics Model : Manage pipeline...
Friday, 23rd October, 2015
Time : 01:00 PM EDT | 10:00 AM PDT
EMA & US FDA view of regulatory aspects of pha...
Friday, 19th February, 2016
Time : 01:00 PM EDT | 10:00 AM PDT
FDA and Safety Monitoring
Friday, 15th July, 2016
Time : 01:00 PM EDT | 10:00 AM PDT
Panel Discussion on Quality Management Principle...
Monday, 20th February, 2017
Time : 04:00 PM IST | 11:30 AM BST
Back to the basics: Refresh your epidemiology kn...
Friday, 17th July, 2020
Time : 121:00 PM EST | 10:00 AM PST
2021 Guidelines for Office and Outpatient Visits...
Friday, 8th January, 2021
Time : 01:00 PM EDT | 10:00 AM PDT
Latest News
Monday, 12th April, 2021
Time : |
Recorded Webinar
2021 Guidelines for Office and Outpatient Visits
timelapse 60 mins with 10-15 mins of Q and A
Note:
This webinar occured in the past
Along with recorded webinar, copy of presentation slides will be shared
Recorded Webinar can be played unlimited times
Speaker/Presenter
Biopractice
Short Abstract
The current guidelines for documentation of office and outpatient visits were implemented in the early 90’s and have become cumbersome and outdated for the current medical provider. For 2021 CMS and the AMA have joined together to create and implement new documentation guidelines for office and outpatient visits that must be used starting January 1, 2021.
Why should you attend
The providers and staff involved in billing, coding, and documentation all need to understand the new guidelines to ensure the documentation supports the services being reported to the insurance companies. If the documentation does not support the services, and the provider is audited, there may be fees and penalties involved due to improper coding. These new guidelines make documentation easier as they are more relevant to medicine and the treating of patients today, and should reduce the time spent documenting irrelevant elements to the care of the patient.
In order for a medical provider to be compliant with the documentation and levels of service involved in office and outpatient visits, they must follow the current guidelines for documentation. Beginning January 1, 2021 there are new guidelines being implemented for all medical claims, regardless of insurance. These guidelines are published in the CPT® manual with the explanation of what they are and how to apply them. There are new ways of determining the level of service on the documentation to support time or medical decision making. Providers may have to change their documentation and templates based on these new guidelines and will need to know what is required.
The presentation will cover the following areas:
- New elements for choosing the level of office and outpatient visit
- What is included when choosing a visit by time.
- Looking at the new and improved table of risk
- New categories for medical decision making
- How does the social determinants of health affect the new guidelines
- Counting individual diagnostic testing and medical record review for MDM
- Whose time with the patient can be used for choosing a visit on time
Content Disclaimer
Contents in our website are from external websites. Links to and content from external website are provided for the convenience of users. Biopractice.com takes no responsibility for the content of such links and websites.